Basilea Pharmaceutica Ltd. (SWISS: BSLN) announces that the U.S. Food and Drug Administration (FDA) has accepted the response submitted by the sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (PRD) as complete. The Complete Response … (source: Medical News Today)
– RSS news feeds and Widgets on Feedzilla.com
Tags: Administration, basilea pharmaceutica, bsln, Ceftobiprole, com, food and drug, food and drug administration, food and drug administration fda, Ltd, medical news, NDA, news, news today, Pharmaceutica, pharmaceutical research, PRD, rss news feeds, submission, widgets
